纳米颗粒
缺氧(环境)
肿瘤缺氧
灌注
材料科学
全身给药
癌症研究
医学
生物医学工程
纳米技术
体内
放射治疗
化学
内科学
氧气
生物
生物技术
有机化学
作者
Mukaddes Izci,Christy Maksoudian,Filipa Gonçalves,Irati Pérez Gilabert,Carla Ríos-Luci,Eduardo Bolea-Fernández,Frank Vanhaecke,Bella B. Manshian,Stefaan J. Soenen
标识
DOI:10.1002/adhm.202300594
摘要
Abstract The ability to improve nanoparticle delivery to solid tumors is an actively studied domain, where various mechanisms are looked into. In previous work, the authors have looked into nanoparticle size, tumor vessel normalization, and disintegration, and here it is aimed to continue this work by performing an in‐depth mechanistic study on the use of ciRGD peptide co‐administration. Using a multiparametric approach, it is observed that ciRGD can improve nanoparticle delivery to the tumor itself, but also to tumor cells specifically better than vessel normalization strategies. The effect depends on the level of tumor perfusion, hypoxia, neutrophil levels, and vessel permeability. This work shows that upon characterizing tumors for these parameters, conditions can be selected that can optimally benefit from ciRGD co‐administration as a means to improve NP delivery to solid tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI